148 related articles for article (PubMed ID: 8709165)
1. [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].
Iwakura K; Tamura H; Yamashita Y; Watanabe M; Sumi N; Shindo Y; Ando M; Kojima M
J Toxicol Sci; 1996 Jun; 21 Suppl 1():241-57. PubMed ID: 8709165
[TBL] [Abstract][Full Text] [Related]
2. [Single-dose toxicity studies of prulifloxacin (NM441) in mice, rats and dogs and the active metabolite (NM394) in rats].
Shimazu H; Ishikawa Y; Nishiguchi Y; Yoshida M; Iwakura K; Sumi N; Shindo Y
J Toxicol Sci; 1996 Jun; 21 Suppl 1():33-44. PubMed ID: 8709168
[TBL] [Abstract][Full Text] [Related]
3. [Mutagenicity studies of lactitol (NS-4)].
Iwakura K; Tamura H; Watanabe M; Sumi N
J Toxicol Sci; 1994 Nov; 19 Suppl 3():487-97. PubMed ID: 7837301
[TBL] [Abstract][Full Text] [Related]
4. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
Tamura H; Yamashita Y; Kitayama E; Iwakura K; Watanabe M; Sumi N
J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614
[TBL] [Abstract][Full Text] [Related]
5. [Mutagenicity studies of montirelin hydrate (NS-3)].
Iwakura K; Tamura H; Yamashita Y; Kitayama E; Hamasu Y; Nagasawa H; Watanabe M; Sumi N
J Toxicol Sci; 1995 Dec; 20 Suppl 2():325-34. PubMed ID: 9019565
[TBL] [Abstract][Full Text] [Related]
6. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
Otsuka M; Kajiwara Y; Ajimi S; Shimazaki H; Kikuno T; Ogura S; Inai T; Kakimoto K; Tamura H; Watanabe M; Sumi N
J Toxicol Sci; 1997 Apr; 22 Suppl 1():251-61. PubMed ID: 9170613
[TBL] [Abstract][Full Text] [Related]
7. [Cytotoxicity and mutagenicity studies of T-3761].
Nakamura S; Hayashi T; Nojima Y; Nishida N; Kawamura Y; Kodama T
Jpn J Antibiot; 1995 Jun; 48(6):868-77. PubMed ID: 7666585
[TBL] [Abstract][Full Text] [Related]
8. [A mutagenicity study of calcipotriol (MC903)].
Kitagaki T; Oguma Y; Yokota F; Ono M; Shirakawa K; Nagata M; Konishi R
J Toxicol Sci; 1996 Jul; 21 Suppl 2():465-74. PubMed ID: 8741426
[TBL] [Abstract][Full Text] [Related]
9. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
Ohuchida A; Kouchi Y; Sato S; Maeda Y
J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity tests of mofezolac (N-22).
Ohuchida A; Furukawa A
J Toxicol Sci; 1990 Jun; 15 Suppl 2():239-51. PubMed ID: 2231792
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
Jin SE; Lee MY; Seo CS; Ha H; Kim JY; Shin HK
J Ethnopharmacol; 2017 Apr; 202():122-126. PubMed ID: 27916588
[TBL] [Abstract][Full Text] [Related]
12. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity tests on propiverine hydrochloride.
Ohuchida A; Furukawa A
J Toxicol Sci; 1989 May; 14(2):131-41. PubMed ID: 2778853
[TBL] [Abstract][Full Text] [Related]
14. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity tests of polyoxyethylene hydrogenated castor oil 60 (HCO-60).
Hirai O; Miyamae Y; Zaizen K; Miyamoto A; Takashima M; Hattori Y; Ohara K; Mine Y
J Toxicol Sci; 1994 May; 19(2):89-96. PubMed ID: 8072043
[TBL] [Abstract][Full Text] [Related]
16. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R
J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
[TBL] [Abstract][Full Text] [Related]
17. [Mutagenicity studies of prednisolone farnesylate (PNF)].
Otsuka M; Ajimi S; Kajiwara Y; Ogura S; Kakimoto K; Inai T; Tanaka H; Ohuchida A
J Toxicol Sci; 1992 Nov; 17 Suppl 3():269-81. PubMed ID: 1293327
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity testing of sodium formononetin-3'-sulphonate (Sul-F) by assessing bacterial reverse mutation, chromosomal aberrations and micronucleus tests.
Li C; Gao Y; Wang Y; Li G; Fan X; Li Y; Guo C; Tao J
Regul Toxicol Pharmacol; 2017 Jun; 86():374-378. PubMed ID: 28408196
[TBL] [Abstract][Full Text] [Related]
19. Induction of micronucleated erythrocytes by recombinant human erythropoietin.
Yajima N; Kurata Y; Sawai T; Takeshita Y
Mutagenesis; 1993 May; 8(3):221-9. PubMed ID: 8332084
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity test of cefodizime sodium.
Ohuchida A; Yoshida R
J Toxicol Sci; 1988 Jun; 13 Suppl 1():245-56. PubMed ID: 3050144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
